Modulation of platelet agregation of rats treated with LPS by resctive oxygen species / Modulação da agregação de plaquetas de ratos tratados com LPS por especies reativas de oxigenio

AUTOR(ES)
DATA DE PUBLICAÇÃO

2009

RESUMO

LPS activates different cells, including platelets, causing the release of inflammatory mediators like nitric oxide, interleukins and reactive oxygen species (ROS). It has been published several reports about the effects of LPS on platelet reactivity but the results are still conflicting and the mechanisms underlying the LPS signaling pathway remains unclear. Therefore, we have used platelets isolated from LPS-treated rats to investigate the role of ROS in modulating the platelet aggregation. Rats were injected with LPS (1 mg/kg, i.p.), and at 2 to 72 h thereafter, platelet aggregation was evaluated. Reactive-oxygen species was determined 2’,7’-dichlorofluorescein diacetate (DCFH-DA). ADP-induced platelet aggregation was time-dependently reduced at 4 to 72 h after LPS injection, and this inhibitory effect was augmented when platelets were incubated with PEG-SOD, PEG-catalase or N-acetylcysteine (NAC). Treatment of rats with NAC (150 mg/kg i.p., 30 min after LPS injection) prevented the inhibition of platelet aggregation. Incubation of control platelets with LPS (100 and 300 µg/ml, 2 h) in vitro did not affect the ROS production. In ADP-activated platelets of LPS-treated rats, ROS production was significantly higher compared with control rats. This increased ROS production was significantly reduced when platelets were incubated in vitro with the NADPH-oxidase inhibitor (DPI). Treatment of rats with NAC prevented the increased ROS production by LPS. In conclusion, systemic or in situ ROS production in response to in vivo LPS treatment plays an important modulatory role on platelet aggregation.

ASSUNTO(S)

especies reativas de oxigenio lipopolysaccharides plaquetas (sangue) lipopolissacarideos blood platelets reactive oxygen species

Documentos Relacionados